Key Developments: Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

67.80USD
11 Jul 2014
Price Change (% chg)

$0.09 (+0.14%)
Prev Close
$67.71
Open
$67.75
Day's High
$67.90
Day's Low
$67.20
Volume
2,583,545
Avg. Vol
5,209,216
52-wk High
$79.37
52-wk Low
$59.20

Search Stocks

Latest Key Developments (Source: Significant Developments)

Express Scripts Holding Co gives Q2 2014 EPS guidance below analysts' estimates; lowers FY 2014 earnings guidance
Tuesday, 29 Apr 2014 04:02pm EDT 

Express Scripts Holding Co:Expects Q2 2014 adjusted earnings per share of $1.20 to $1.24.Expects FY 2014 adjusted EBITDA of $6.775 to $6.975 billion.Expects FY 2014 adjusted earnings per share of $4.82 to $4.94.Q2 2014 EPS of $1.27 - Thomson Reuters I/B/E/S.FY 2014 EBITDA of $6.982 billion and EPS of $4.95 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co's United BioSource Corp partnered with RT Oncology Services Corp
Monday, 31 Mar 2014 08:30am EDT 

Express Scripts Holding Co:United BioSource Corp, subsidiary has been named preferred oncology clinical research partner by RT Oncology Services Corp.Agreement seeks to improve patient care by accelerating clinical research in the U.S.  Full Article

Express Scripts Holding Co announces increase in authorization of share repurchase program - Form 8-K
Wednesday, 5 Mar 2014 04:02pm EST 

Express Scripts Holding Co:Says on March 5, approved an increase in the authorized number of shares that may be repurchased under the company‚Äôs share repurchase program by an additional 65 million shares, or a total authorization of 140 million shares.  Full Article

Express Scripts Holding Co raises FY 2014 earnings guidance-conference call
Monday, 3 Mar 2014 07:50pm EST 

Express Scripts Holding Co:Expects FY 2014 EBITDA growth of 7 pct to 10 pct.Expects FY 2014 EPS growth of 18 pct to 21 pct.Reported EBITDA of $6.664 bln and EPS of $4.30 in FY 2013.FY 2014 EBITDA of $6.967 bln and EPS of $4.94 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co gives FY 2014 EPS outlook; EBITDA outlook below analysts' estimates
Thursday, 20 Feb 2014 04:49pm EST 

Express Scripts Holding Co:Expects FY 2014 adjusted EBITDA of $6.850 to $7.050 bln.Expects FY 2014 Adjusted earnings per share of $4.88 to $5.00.FY 2014 EBITDA of $7.218 bln, EPS of $4.93 - Thomson Reuters I/B/E/S.  Full Article

Express Scripts Holding Co names Tim Wentworth as President
Tuesday, 28 Jan 2014 04:01pm EST 

Express Scripts Holding Co:Says Tim Wentworth has been appointed as the President of the company.  Full Article

Express Scripts Holding Co names Cathy R. Smith chief financial officer
Tuesday, 14 Jan 2014 08:00am EST 

Express Scripts Holding Co:Says that Cathy R. Smith will join the company as executive vice president and chief financial officer, effective Feb. 10.  Full Article

RainTree Oncology Services Announces Distribution Agreement with Express Scripts
Friday, 13 Dec 2013 08:00am EST 

RT Oncology Services Corporation and Express Scripts Holding Co:Says they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.Says CuraScript Specialty Distribution, an Express Scripts business, will provide pharmaceuticals, oncology supportive therapies, vaccines, biologicals and other products (excluding intravenous and infusible oncology medications) to RainTree members.Says RainTree community oncology practice membership currently includes a total of approximately 700 physicians in over 50 practices nationwide and is continuing to expand as new members join.Says RainTree will not be distributing or marketing intravenous or infusible oncology medications through July 1, 2014.  Full Article

Express Scripts Holding Co announces accelerated share repurchase transaction
Tuesday, 10 Dec 2013 08:32am EST 

Express Scripts Holding Co:Enters into an accelerated share repurchase, or ASR, transaction with Bank of America, N.A. to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,500 mln.Says it will be funded from cash on hand.Says under the terms of the transaction, Express Scripts will initially receive about 20.1 mln shares of its stock.Says the ASR transaction is expected to be completed by end of the Q2 2014.  Full Article

Express Scripts Holding Co Raises Low End of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates ; Issues Q4 2013 EPS Guidance In Line With Analysts' Estimates
Thursday, 24 Oct 2013 04:57pm EDT 

Express Scripts Holding Co for fiscal 2013, it expects adjusted earnings per diluted share (EPS) from continuing operations attributable to Express Scripts, in the range of $4.30 to $4.34, or 15% to 16% growth over fiscal 2012. For fourth quarter of 2013, it expects EPS to be between $1.09 and $1.13. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $4.31 for fiscal 2013 and EPS of $1.12 for the fourth quarter of 2013.  Full Article

Fitch Rates Express Scripts' Proposed Bond Offering 'BBB'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, June 02 (Fitch) Fitch Ratings has assigned a 'BBB' rating to the proposed senior unsecured bond issuance by Express Scripts Holding Company (NYSE:ESRX). Proceeds from the issuance are expected to be used for the redemption of ESRX's $900 million and $1.25 billion of unsecured bonds due November 2014 and November 2016, respectively, and for general corporate purposes (including some share repurchase). Fitch currently rates

Search Stocks